A detailed history of Sands Capital Management, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Sands Capital Management, LLC holds 5,648,655 shares of EW stock, worth $370 Million. This represents 1.61% of its overall portfolio holdings.

Number of Shares
5,648,655
Previous 5,802,552 2.65%
Holding current value
$370 Million
Previous $554 Million 5.9%
% of portfolio
1.61%
Previous 1.63%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$84.3 - $94.31 $13 Million - $14.5 Million
-153,897 Reduced 2.65%
5,648,655 $522 Million
Q1 2024

May 14, 2024

SELL
$72.54 - $95.56 $21.8 Million - $28.8 Million
-301,150 Reduced 4.93%
5,802,552 $554 Million
Q4 2023

Feb 13, 2024

BUY
$61.71 - $77.76 $96.7 Million - $122 Million
1,567,526 Added 34.56%
6,103,702 $465 Million
Q3 2023

Nov 14, 2023

SELL
$69.28 - $93.38 $8.8 Million - $11.9 Million
-127,037 Reduced 2.72%
4,536,176 $314 Million
Q2 2023

Aug 15, 2023

SELL
$81.41 - $94.33 $126 Million - $146 Million
-1,544,611 Reduced 24.88%
4,663,213 $440 Million
Q1 2023

May 12, 2023

SELL
$74.26 - $84.51 $97.2 Million - $111 Million
-1,308,261 Reduced 17.41%
6,207,824 $514 Million
Q4 2022

Feb 13, 2023

SELL
$68.3 - $87.44 $197 Million - $253 Million
-2,889,817 Reduced 27.77%
7,516,085 $561 Million
Q3 2022

Nov 09, 2022

SELL
$82.37 - $107.29 $108 Million - $140 Million
-1,305,885 Reduced 11.15%
10,405,902 $860 Million
Q2 2022

Aug 12, 2022

BUY
$86.5 - $128.27 $821,923 - $1.22 Million
9,502 Added 0.08%
11,711,787 $1.11 Billion
Q1 2022

May 13, 2022

SELL
$101.96 - $128.34 $103 Million - $130 Million
-1,010,762 Reduced 7.95%
11,702,285 $1.38 Billion
Q4 2021

Feb 11, 2022

SELL
$106.37 - $130.68 $89.1 Million - $109 Million
-837,369 Reduced 6.18%
12,713,047 $1.65 Billion
Q3 2021

Nov 03, 2021

BUY
$102.91 - $122.75 $11.7 Million - $14 Million
113,882 Added 0.85%
13,550,416 $1.53 Billion
Q2 2021

Aug 16, 2021

BUY
$83.84 - $104.76 $38.2 Million - $47.8 Million
456,072 Added 3.51%
13,436,534 $1.39 Billion
Q1 2021

May 17, 2021

BUY
$78.68 - $90.67 $1.02 Billion - $1.18 Billion
12,980,462 New
12,980,462 $1.09 Billion
Q1 2021

May 12, 2021

SELL
$78.68 - $90.67 $914 Million - $1.05 Billion
-11,614,640 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$71.69 - $91.23 $32.2 Million - $41 Million
-448,955 Reduced 3.72%
11,614,640 $1.06 Billion
Q3 2020

Nov 16, 2020

SELL
$67.19 - $87.44 $24.5 Million - $31.9 Million
-364,615 Reduced 2.93%
12,063,595 $963 Million
Q2 2020

Aug 11, 2020

BUY
$57.54 - $76.95 $461 Million - $617 Million
8,015,958 Added 181.67%
12,428,210 $859 Million
Q1 2020

May 14, 2020

SELL
$52.41 - $81.0 $86.9 Million - $134 Million
-1,657,307 Reduced 27.31%
4,412,252 $832 Million
Q4 2019

Feb 13, 2020

SELL
$71.7 - $82.09 $95.4 Million - $109 Million
-1,330,525 Reduced 17.98%
6,069,559 $1.42 Billion
Q3 2019

Nov 14, 2019

SELL
$61.55 - $75.43 $6.24 Million - $7.64 Million
-101,324 Reduced 1.35%
7,400,084 $1.63 Billion
Q2 2019

Aug 14, 2019

SELL
$55.74 - $64.41 $10.8 Million - $12.4 Million
-192,926 Reduced 2.51%
7,501,408 $1.39 Billion
Q1 2019

May 15, 2019

SELL
$47.89 - $64.05 $12.6 Million - $16.8 Million
-262,992 Reduced 3.31%
7,694,334 $1.47 Billion
Q4 2018

Feb 14, 2019

SELL
$46.41 - $56.94 $19.3 Million - $23.7 Million
-416,640 Reduced 4.98%
7,957,326 $1.22 Billion
Q3 2018

Nov 14, 2018

BUY
$45.7 - $58.03 $66.6 Million - $84.5 Million
1,456,534 Added 21.06%
8,373,966 $1.46 Billion
Q2 2018

Aug 14, 2018

BUY
$42.45 - $51.3 $16.8 Million - $20.3 Million
395,268 Added 6.06%
6,917,432 $1.01 Billion
Q1 2018

May 15, 2018

SELL
$37.19 - $47.45 $16.1 Million - $20.6 Million
-433,871 Reduced 6.24%
6,522,164 $910 Million
Q4 2017

Feb 14, 2018

SELL
$33.79 - $39.39 $9.47 Million - $11 Million
-280,400 Reduced 3.87%
6,956,035 $784 Million
Q3 2017

Nov 14, 2017

SELL
$36.29 - $38.83 $14.4 Million - $15.4 Million
-396,740 Reduced 5.2%
7,236,435 $791 Million
Q2 2017

Aug 14, 2017

BUY
N/A
7,633,175
7,633,175 $903 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.5B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Sands Capital Management, LLC Portfolio

Follow Sands Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sands Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sands Capital Management, LLC with notifications on news.